Axial3D Limited

Based in the UK, Axial3D Limited specializes in 3D imaging, modeling, and surgical planning solutions for the healthcare sector, enhancing surgical precision and patient outcomes through innovative technology. Founded in 2014, Axial3D Limited is based in Belfast, UK, and focuses on developing advanced 3D solutions for the healthcare industry. The company has been involved in 4 deals, with its most recent funding round occurring on December 17, 2024. Axial3D raised GBP 14.

4 million in this round, which included participation from investors such as 57 Stars, Clarendon Fund Managers, and Innovate UK. The company is led by CEO Roger Johnston and was founded by Daniel Crawford. Axial3D specializes in advanced 3D imaging, modeling, and surgical planning solutions tailored for the healthcare sector, specifically targeting medical device companies and hospitals. Their core offerings empower these organizations to deliver personalized surgical care, leveraging data-driven 3D technologies to enhance precision and improve patient outcomes.

These solutions include automated segmentation and planning tools that facilitate streamlined workflows, making it easier for healthcare professionals to integrate patient-specific considerations into surgical planning and device development. Axial3D's products serve a diverse client base that includes orthopedic surgeons, hospitals, and medical device manufacturers primarily in North America and Europe, transforming surgical care practices within these key markets. Axial3D generates revenue through a structured business model that focuses on partnerships with medical device companies and healthcare providers. Their offerings are typically provided on a subscription basis, allowing clients to access their suite of 3D solutions and services tailored to specific surgical needs.

This transactional framework enables hospitals and medical device manufacturers to integrate Axial3D's technology into their existing workflows, enhancing their service delivery models. Pricing plans accommodate various client needs, reflecting the value of personalized surgical solutions, including flagship offerings that may be trademarked within the industry. Transactions occur directly between Axial3D and its clients, reinforcing a B2B structure that prioritizes long-term partnerships and innovation in patient care. In December 2024, Axial3D Limited raised GBP 14.

4 million in venture funding which will be utilized to expedite establishing patient-specific surgery as a standard practice worldwide. The company is focused on launching new products designed to enhance their 3D imaging and surgical planning capabilities. Additionally, Axial3D plans to expand its presence in North America and Europe, targeting specific healthcare markets to broaden its reach and client base. This strategic growth initiative aligns with the recent funding, which is intended to support the development of innovative solutions that further integrate personalized surgical care.